Dexmedetomidine 100 mcg/mL Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) Infusion/Injection
Available Strengths: 100 mcg/mL
Reference Brands: Precedex(US); Dexdor(EU)
Category: Critical Care
Dexmedetomidine is a sedation agent used in ICUs and surgeries, available as 100 mcg/mL concentrate and 4 mcg/mL ready-to-use infusions. Brands include Precedex, Dexdor, and Accord. It’s a key anesthetic product in pharma B2B hospital procurement, widely used for conscious sedation and ventilated patient care.
Product Description:
Dexmedetomidine is a highly selective alpha-2 adrenergic agonist used for sedation in ICU and surgical settings without causing respiratory depression. Available as a 100 mcg/mL concentrate in 2 mL and 4 mL vials, and as ready-to-use infusions (4 mcg/mL in 50 mL and 100 mL), it ensures flexible dosing and efficient workflow. In the US, Precedex by Pfizer and generic alternatives are widely used. The EU features Dexdor (Orion), Accord, and B. Braun formulations. Dexmedetomidine is a critical care drug frequently procured via pharma B2B platforms for operating rooms, ICUs, and procedural sedation in institutional healthcare settings.
Dexmedetomidine — third party manufacturing & bulk supply
Dexmedetomidine 100 mcg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Dexmedetomidine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dexmedetomidine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dexmedetomidine injection is used for sedation of initially intubated and mechanically ventilated patients in intensive care units. It is also used for procedural sedation in non-intubated patients before or during surgical and diagnostic procedures. It provides sedation with minimal respiratory depression.
Dexmedetomidine injection is made from dexmedetomidine hydrochloride. It is a selective alpha-2 adrenergic receptor agonist that produces sedative and analgesic effects by reducing sympathetic nervous system activity.
The most well-known trade name is Precedex.
Precedex was originally developed and marketed by Hospira. It is now marketed by Pfizer in many countries. Generic dexmedetomidine injection is also manufactured by multiple pharmaceutical companies worldwide.
The generic name is dexmedetomidine hydrochloride.
The brand name is Precedex.
Dexmedetomidine injection is manufactured in GMP-certified pharmaceutical facilities in the United States, Europe, India, and other regulated markets depending on the marketing authorization holder and supplier. Specific manufacturing sites vary by brand and batch.
Related Products
Ringer's Lactate
Strength:
100 mL, 250 mL, 500 mL, 1000ml
Form: Infusion
Reference Brands: Generic formulations marketed under different names
View Details
Rolapitant Hydrochlorid
Strength:
90 mg
Form: Tablets
Reference Brands: Varubi(USA/LATAM), Varuby(EU)
View Details
Conivaptan Hydrochloride
Strength:
20 mg/100 mL
Form: Infusion
Reference Brands: Vaprisol (USA)
View Details
Fitusiran
Strength:
50 mg/0.5 ml, 20 mg/0.2ml
Form: injection (prefilled syringe)
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
